These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 24045940)
1. Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth. Tanida S; Akita K; Ishida A; Mori Y; Toda M; Inoue M; Ohta M; Yashiro M; Sawada T; Hirakawa K; Nakada H J Biol Chem; 2013 Nov; 288(44):31842-52. PubMed ID: 24045940 [TBL] [Abstract][Full Text] [Related]
2. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Beatson R; Tajadura-Ortega V; Achkova D; Picco G; Tsourouktsoglou TD; Klausing S; Hillier M; Maher J; Noll T; Crocker PR; Taylor-Papadimitriou J; Burchell JM Nat Immunol; 2016 Nov; 17(11):1273-1281. PubMed ID: 27595232 [TBL] [Abstract][Full Text] [Related]
3. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer. Läubli H; Pearce OM; Schwarz F; Siddiqui SS; Deng L; Stanczak MA; Deng L; Verhagen A; Secrest P; Lusk C; Schwartz AG; Varki NM; Bui JD; Varki A Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14211-6. PubMed ID: 25225409 [TBL] [Abstract][Full Text] [Related]
4. A soluble form of Siglec-9 provides an antitumor benefit against mammary tumor cells expressing MUC1 in transgenic mice. Tomioka Y; Morimatsu M; Nishijima K; Usui T; Yamamoto S; Suyama H; Ozaki K; Ito T; Ono E Biochem Biophys Res Commun; 2014 Jul; 450(1):532-7. PubMed ID: 24924635 [TBL] [Abstract][Full Text] [Related]
5. Expression of ligands for Siglec-8 and Siglec-9 in human airways and airway cells. Jia Y; Yu H; Fernandes SM; Wei Y; Gonzalez-Gil A; Motari MG; Vajn K; Stevens WW; Peters AT; Bochner BS; Kern RC; Schleimer RP; Schnaar RL J Allergy Clin Immunol; 2015 Mar; 135(3):799-810.e7. PubMed ID: 25747723 [TBL] [Abstract][Full Text] [Related]
6. Galectin-3 binds to MUC1-N-terminal domain and triggers recruitment of β-catenin in MUC1-expressing mouse 3T3 cells. Tanida S; Mori Y; Ishida A; Akita K; Nakada H Biochim Biophys Acta; 2014 Jun; 1840(6):1790-7. PubMed ID: 24561267 [TBL] [Abstract][Full Text] [Related]
7. Studies on the Detection, Expression, Glycosylation, Dimerization, and Ligand Binding Properties of Mouse Siglec-E. Siddiqui S; Schwarz F; Springer S; Khedri Z; Yu H; Deng L; Verhagen A; Naito-Matsui Y; Jiang W; Kim D; Zhou J; Ding B; Chen X; Varki N; Varki A J Biol Chem; 2017 Jan; 292(3):1029-1037. PubMed ID: 27920204 [TBL] [Abstract][Full Text] [Related]
8. First Evidence for a Role of Siglec-8 in Breast Cancer. Trebo A; Ditsch N; Degenhardt T; Kuhn C; Rahmeh M; Schmoeckel E; Mayr D; Czogalla B; Kolben T; Meister S; Mahner S; Jeschke U; Hester A Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670444 [TBL] [Abstract][Full Text] [Related]
9. Binding of a sialic acid-recognizing lectin Siglec-9 modulates adhesion dynamics of cancer cells via calpain-mediated protein degradation. Sabit I; Hashimoto N; Matsumoto Y; Yamaji T; Furukawa K; Furukawa K J Biol Chem; 2013 Dec; 288(49):35417-27. PubMed ID: 24145038 [TBL] [Abstract][Full Text] [Related]
10. Siglec Signaling in the Tumor Microenvironment. van Houtum EJH; Büll C; Cornelissen LAM; Adema GJ Front Immunol; 2021; 12():790317. PubMed ID: 34966391 [TBL] [Abstract][Full Text] [Related]
11. Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma. Santegoets KCM; Gielen PR; Büll C; Schulte BM; Kers-Rebel ED; Küsters B; Bossman SAJFH; Ter Laan M; Wesseling P; Adema GJ Cancer Immunol Immunother; 2019 Jun; 68(6):937-949. PubMed ID: 30953118 [TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive Siglec-E ligands on mouse aorta are up-regulated by LPS via NF-κB pathway. Liu H; Zheng Y; Zhang Y; Li J; Fernandes SM; Zeng D; Li X; Schnaar RL; Jia Y Biomed Pharmacother; 2020 Feb; 122():109760. PubMed ID: 31918287 [TBL] [Abstract][Full Text] [Related]
13. mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2. Yu Z; Maoui M; Wu L; Banville D; Shen S Biochem J; 2001 Feb; 353(Pt 3):483-92. PubMed ID: 11171044 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement. Yokoi H; Choi OH; Hubbard W; Lee HS; Canning BJ; Lee HH; Ryu SD; von Gunten S; Bickel CA; Hudson SA; Macglashan DW; Bochner BS J Allergy Clin Immunol; 2008 Feb; 121(2):499-505.e1. PubMed ID: 18036650 [TBL] [Abstract][Full Text] [Related]
15. Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1. Chen GY; Brown NK; Wu W; Khedri Z; Yu H; Chen X; van de Vlekkert D; D'Azzo A; Zheng P; Liu Y Elife; 2014 Sep; 3():e04066. PubMed ID: 25187624 [TBL] [Abstract][Full Text] [Related]
16. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9. Ikehara Y; Ikehara SK; Paulson JC J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262 [TBL] [Abstract][Full Text] [Related]
17. Multivalent Interactions of Human Primary Amine Oxidase with the V and C22 Domains of Sialic Acid-Binding Immunoglobulin-Like Lectin-9 Regulate Its Binding and Amine Oxidase Activity. Elovaara H; Parkash V; Fair-Mäkelä R; Salo-Ahen OM; Guédez G; Bligt-Lindén E; Grönholm J; Jalkanen S; Salminen TA PLoS One; 2016; 11(11):e0166935. PubMed ID: 27893774 [TBL] [Abstract][Full Text] [Related]
18. Immunoregulatory Siglec ligands are abundant in human and mouse aorta and are up-regulated by high glucose. Zhang Y; Zheng Y; Li J; Nie L; Hu Y; Wang F; Liu H; Fernandes SM; Zhong Q; Li X; Schnaar RL; Jia Y Life Sci; 2019 Jan; 216():189-199. PubMed ID: 30471282 [TBL] [Abstract][Full Text] [Related]